Ann: Trading Halt, page-35

You got to remember our share register is riddled with people who own very little shares, that’s all well and good pending peoples circumstances, but these guys are the ones who will sell and take a shinny profit on day one or two of the announcement ( hoping for a rinse repeat scenario ) to buy back in cheaper. Hopefully with this announcement, we see some new money and institutional investment for the New financial year

Theres not a lot of confidence in the biotech market, but over time confidence will be restored, while Orthocell keep chipping away, finishing trials, getting approvals / partnerships. This alone should restore a little confidence, 12 months we should start to see a revenue stream from Striate+, enough money bank to continue trials and approvals on other products like

Ortho-ATI

Ortho-Tendon

Ortho-ACL ( rope )

Remplir ( nerve )

Partner these guys up in the next year or two and we should see our companies worth ten times what it is today.

No more mister negative lol